Schrodinger Revenue 2019-2023 | SDGR

Schrodinger revenue from 2019 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Schrodinger Annual Revenue
(Millions of US $)
2023 $217
2022 $181
2021 $138
2020 $108
2019 $86
2018 $67
Schrodinger Quarterly Revenue
(Millions of US $)
2023-12-31 $74
2023-09-30 $43
2023-06-30 $35
2023-03-31 $65
2022-12-31 $57
2022-09-30 $37
2022-06-30 $38
2022-03-31 $49
2021-12-31 $46
2021-09-30 $30
2021-06-30 $30
2021-03-31 $32
2020-12-31 $33
2020-09-30 $26
2020-06-30 $23
2020-03-31 $26
2019-12-31 $26
2019-09-30 $20
2019-06-30 $19
2019-03-31 $21
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.794B $0.217B
Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $39.354B 21.89
Inspire Medical Systems (INSP) United States $7.087B 0.00
IRhythm Technologies (IRTC) United States $3.621B 0.00
Axonics (AXNX) United States $3.390B 0.00
10x Genomics (TXG) United States $3.287B 0.00
Enovis (ENOV) United States $3.042B 23.11
Azenta (AZTA) United States $2.930B 238.82
Olink Holding AB (publ) (OLK) Sweden $2.760B 0.00
Hims & Hers Health (HIMS) United States $2.642B 0.00
Privia Health (PRVA) United States $2.231B 98.95
Omnicell (OMCL) United States $1.306B 31.94
Phreesia (PHR) United States $1.305B 0.00
Definitive Healthcare (DH) United States $0.856B 0.00
Standard BioTools (LAB) United States $0.743B 0.00
Fulgent Genetics (FLGT) United States $0.617B 0.00
Talkspace (TALK) United States $0.530B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.330B 0.00
Health Catalyst (HCAT) United States $0.328B 0.00
Clover Health Investments (CLOV) United States $0.312B 0.00
Pulmonx (LUNG) United States $0.289B 0.00
P3 Health Partners (PIII) United States $0.162B 0.00
MSP Recovery (LIFW) United States $0.158B 0.00
American Well (AMWL) United States $0.157B 0.00
Butterfly Network (BFLY) United States $0.154B 0.00
Augmedix (AUGX) United States $0.138B 0.00
Outset Medical (OM) United States $0.127B 0.00
TruBridge (TBRG) United States $0.119B 5.06
111 (YI) China $0.091B 0.00
SHL Telemedicine (SHLT) Israel $0.079B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.047B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.032B 0.00
Movano (MOVE) United States $0.027B 0.00
Cue Health (HLTH) United States $0.024B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
Strata Skin Sciences (SSKN) United States $0.019B 0.00
Akili (AKLI) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.015B 0.00
Biotricity (BTCY) United States $0.014B 0.00
Centogene (CNTG) Germany $0.013B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00